Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 23;63(9):e00865-19.
doi: 10.1128/AAC.00865-19. Print 2019 Sep.

Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in Aspergillus Species Received within a Surveillance Program on Antifungal Resistance in Spain

Olga Rivero-Menendez  1 , Juan Carlos Soto-Debran  1 , Narda Medina  1 , Jose Lucio  1 , Emilia Mellado  1   2 , Ana Alastruey-Izquierdo  3   2
Affiliations

Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in Aspergillus Species Received within a Surveillance Program on Antifungal Resistance in Spain

Olga Rivero-Menendez et al. Antimicrob Agents Chemother. .

Abstract

Antifungal resistance is one of the major causes of the increasing mortality rates for fungal infections, especially for those caused by Aspergillus spp. A surveillance program was established in 2014 in the Spanish National Center for Microbiology for tracking resistance in the most prevalent Aspergillus species. A total of 273 samples were included in the study and were initially classified as susceptible or resistant according to EUCAST breakpoints. Several Aspergillus cryptic species were found within the molecularly identified isolates. Cyp51 mutations were characterized for Aspergillus fumigatus, Aspergillus terreus, and Aspergillus flavussensu stricto strains that were classified as resistant. Three A. fumigatus sensu stricto strains carried the TR34/L98H resistance mechanism, while two harbored G54R substitution and one harbored the TR46/Y121F/T289A mechanism. Seventeen strains had no mutations in cyp51A, with ten of them resistant only to isavuconazole. Three A. terreussensu stricto strains harbored D344N substitution in cyp51A, one of them combined with M217I, and another carried an A249G novel mutation. Itraconazole-resistant A. flavussensu stricto strains harbored P220L and H349R alterations in cyp51A and cyp51C, respectively, that need further investigation on their implication in azole resistance.

Keywords: Aspergillus; Cyp51; EUCAST; antifungal resistance; azoles; isavuconazole; itraconazole; posaconazole; surveillance program; voriconazole.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chen SC, Playford EG, Sorrell TC. 2010. Antifungal therapy in invasive fungal infections. Curr Opin Pharmacol 10:522–530. doi:10.1016/j.coph.2010.06.002. - DOI - PubMed
    1. Kriengkauykiat J, Ito JI, Dadwal SS. 2011. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol 3:175–191. doi:10.2147/CLEP.S12502. - DOI - PMC - PubMed
    1. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. 2011. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 66 Suppl 1:i5–14. doi:10.1093/jac/dkq437. - DOI - PubMed
    1. Sun KS, Tsai CF, Chen SC, Huang WC. 2017. Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: an 11-year follow-up report from Taiwan. PLoS One 12:e0186422. doi:10.1371/journal.pone.0186422. - DOI - PMC - PubMed
    1. Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. 2017. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383–e392. doi:10.1016/S1473-3099(17)30316-X. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources